1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4E)-4-(1,2-oxazol-3-ylidene)-12-oxa-3,5,8-triazatricyclo[7.4.0.02,6]trideca-1(9),2,5,7-tetraene

2.1.2 InChI

InChI=1S/C12H10N4O2/c1-3-17-6-7-8(1)13-5-10-11(7)15-12(14-10)9-2-4-18-16-9/h2,4-5,16H,1,3,6H2/b12-9-

2.1.3 InChI Key

LZMPYSIUWPEIRA-XFXZXTDPSA-N

2.1.4 Canonical SMILES

C1COCC2=C1N=CC3=NC(=C4C=CON4)N=C23

2.1.5 Isomeric SMILES

C1COCC2=C1N=CC3=N/C(=C/4\C=CON4)/N=C23

2.2 Create Date

2006-07-28

3 Chemical and Physical Properties

Molecular Formula	C₁₂H₁₀N₄O₂
Molecular Weight	242.23 g/mol
XLogP3	-0.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	0
Exact Mass	242.08037557 g/mol
Monoisotopic Mass	242.08037557 g/mol
Topological Polar Surface Area	67.6 A^2
Heavy Atom Count	18
Formal Charge	0
Complexity	608
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Ofatumumab

Ofatumumab

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers

1 JDMF

DEVELOPMENTS

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers

2 FDA Orange Book

7 Europe

1 Canada

2 Australia

1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Kirsch Pharma

5 Actylis

1 BASF

3 Gangwal Chemicals

1 Nanjing Bold Chemical

1 Pluviaendo

6 Seppic

EXCIPIENTS BY APPLICATIONS

13 Parenteral

10 Solubilizers

4 Thickeners and Stabilizers

3 Surfactant & Foaming Agents

3 Emulsifying Agents

3 Topical

2 Film Formers & Plasticizers

2 API Stability Enhancers

1 Direct Compression

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

58 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

6 Annual Reports

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

Filters